|Anna Lewandowska-Polak |
Allergic rhinitis is the most frequent atopic disease and is an important health problem that causes impairment in patients activities, social functioning, sleep, school and work. Asthma prevalence ranges from 5 to 20% of the population in different countries and most patients with asthma have rhinitis suggesting the concept of “one airway one disease”. Epidemiologic studies have shown that asthma and rhinitis often coexist in the same patients. Moreover patients with moderate/severe persistent allergic rhinitis may be more likely suffer from asthma than those with intermittent allergic rhinitis and/or a milder form of the disease. The coexistence of rhinitis with asthma appears to impair asthma control. The presence of allergic rhinitis commonly exacerbates asthma increasing the risk of asthma attacks, emergency visits and hospitalizations for asthma.
In April 2008 an Update of ARIA (Allergic Rhinitis and Its Impact on Asthma) guidelines have been published in which classification of rhinitis and management recommendations were validated. In ARIA 2008 document the links between asthma and allergic rhinitis have been confirmed and accented. The epidemiologic evidence and common risk factors were reviewed. The similarities and differences of nasal and bronchial mucosa and mechanisms of allergic inflammation in asthma and rhinitis were presented.
In this article, it is aimed to summarize the newly updated and published version of "Allergic Rhinitis and its Impact on Asthma (ARIA) 2008" and to present the diagnostic and therapeutic consequences of ARIA guidelines. According to them patients with allergic rhinitis should be evaluated for asthma, because the treatment of rhinitis reduces asthma severity and optimize asthma control.
keywords: ARIA, astma oskrzelowa, alergiczny nieżyt nosa, wspólna choroba dróg oddechowych, ARIA, bronchial asthma, allergic rhinitis, “one airway one disease”
pages: from 7 to 13
|estimated time of download (116 kB)|